Replies to post #129579 on Biotech Values

[DewDiligence]

Yervoy’s aggregate US market share among all lines of melanoma therapy was 30% in 3Q11. (Source: today’s BMY CC)

[DewDiligence]

BMY bumps quarterly dividend a penny to $0.34:

http://finance.yahoo.com/news/Bristol-Myers-Squibb-bw-2930955657.html?x=0

At the current share price, the annualized dividend yield is 4.1%.